[1]
Richardson, P., Mitsiades, C., Laubach, J., Conant, C., Hideshima, T., Chauhan, D., Schlossman, R., Ghobrial, I., Munshi, N. and Anderson, K. 2009. Proteasome inhibitors: beyond NFKB inhibition alone and the emerging role of combination therapy in the treatment of multiple myeloma. Hematology Meeting Reports (formerly Haematologica Reports). 2, 5 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i5.753.